[1] | S.A.A. Rizvi, D.P. Do, and A.M. Saleh (2011). Micellar electrokinetic chromatography (MEKC): fundamentals and applications. European Journal of Chemistry, 2(2):276-281. |
[2] | D.P. Do (2011). Drug delivery systems for cancer therapeutics. US Pharmacist, in press. |
[3] | D.P.Do and S.A.A. Rizvi (2011). Epigenetic changes in melanoma and development of epigenetic therapy for melanoma. In M. Murph (Ed.)., Research on Melanoma: A Glimpse into Current Directions and Future Trends, (publisher: Intech), in press. |
[4] | D.P. Do, S.B. Pai, S.A.A. Rizvi and M. J. D'Souza (2010). Development of sulforaphane-encapsulated microspheres for cancer epigenetic therapy. Int. J. Pharm., 386:114-121. |
[5] | D.P.Do (2010). Epigenetic agents for the treatment of hematologic malignancies. US Pharm., 36(1)(Oncology suppl):3-6. |
[6] | G.R. Green and D.P. Do (2009). Purification and analysis of variant and modified histones using two-dimensional polyacrylamide gel electrophoresis (2D-PAGE). Methods Mol. Biol., 464:285-302. |
[7] | N. Akhavein, C. Oettinger, S. Gayakwad, R. Addo, N. Bejagam, J. Bauer, D.P. Do, S. Pollock and M.J. D'Souza (2009). Treatment of adjuvant arthritis using microencapsulated antisense NF-kappa B oligonucleotides. J. Microencapsul., 26(3):223-234. |
[8] | M. Uddin*, D.P. Do*, S. B. Pai*, C. Oettinger and M. D'Souza (2009). A methodology for quantification and characterization of oligonucleotides in albumin microspheres. The Analyst, 134:1483-1489. |